318 results
Page 3 of 16
10-Q
nbz n83x4
3 May 18
Quarterly report
4:08pm
DEF 14A
sewk15frkhjp0qrf
25 Apr 18
Definitive proxy
12:00am
10-K
EX-10.51
fw81d kxudyzf88b
12 Feb 18
Annual report
12:00am
10-K
EX-10.30
v5vq7nip41564ezphd
12 Feb 18
Annual report
12:00am
10-K
EX-10.44
s175xnpjws3k
12 Feb 18
Annual report
12:00am
10-K
EX-10.20
px6x4d4toca3tls
12 Feb 18
Annual report
12:00am
10-K
h1k2a2
12 Feb 18
Annual report
12:00am
10-K
EX-10.32
qts xcy7714w3w
12 Feb 18
Annual report
12:00am
6-K
EX-99.1
6k38l b0qfrkzpct
27 Dec 17
Teva Announces Exclusive Launch of a Generic Version of Reyataz® in the United States
12:00am
6-K
EX-99.1
i4cgu4d3356fodd
18 Aug 17
Teva Announces Exclusive Launch of Generic Axiron® In the United States
12:00am
6-K
EX-99.1
ezzrd0d5hhjjwj cwy
24 Jul 17
Live Filing
12:00am
6-K
EX-99.1
qpfzqt i5
7 Jun 17
Live Filing
12:00am
6-K
EX-99.1
sy08799zo wrfh
26 Oct 16
Collaboration Features First Integration of The Weather Company data with IBM Watson Health Cloud
12:00am
6-K
EX-99.1
k56xn9vae29coqo929
6 Oct 16
Teva and Celltrion Announce Exclusive Biosimilar Commercial Partnership
12:00am
6-K
EX-99.1
br6qz32y6z6heqaxs za
20 Sep 16
Teva and Regeneron Announce Global Collaboration to Develop and Commercialize Fasinumab, an Investigational NGF Antibody for Chronic Pain
12:00am
6-K
EX-99.1
yl4eai rgkzsuyca
18 Aug 16
First Intravenous Anti-IL-5 Biologic Therapy for Severe Eosinophilic Asthma Now Approved in Europe
12:00am
424B5
fzn5li 6da05io
18 Jul 16
Prospectus supplement for primary offering
12:00am
6-K
v98 ob11otm
13 Jul 16
Current report (foreign)
12:00am